Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/29773
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShelest, Borys-
dc.contributor.authorHryhorian, Olena-
dc.contributor.authorSarkis-Ivanova, Vladyslava-
dc.contributor.authorKovalova, Yuliia-
dc.contributor.authorBrek, Valeria-
dc.contributor.authorShelest, Oleksiy-
dc.date.accessioned2021-11-18T09:49:08Z-
dc.date.available2021-11-18T09:49:08Z-
dc.date.issued2021-
dc.identifier.citationTherapeutic strategy in patients with long-lasting essential hypertension with comorbid type 2 diabetes mellitus and obesity / B. O. Shelest, O. V. Hryhorian, V. V. Sarkis-Ivanova, Y. O. Kovalova, V. V. Brek, O. M. Shelest // Arterial Hypertension. – 2021. – Vol. 25, N 1. – P. 39–46.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/29773-
dc.description.abstractPresently the level of blood pressure (BP) control is extremely unsatisfactory in hypertensive patients throughout the world. The aim of our study was to find the optimal drug therapy for patients with hard-to-treat essential hypertension (EH) associated with type 2 diabetes mellitus (T2DM) and obesity, namely the comparison of strategies of fixed and non-fixed combination.en_US
dc.language.isoenen_US
dc.publisherVia Medicaen_US
dc.subjectsingle-pillen_US
dc.subjectcomorbidityen_US
dc.subjectessential hypertensionen_US
dc.subjecttreatmenten_US
dc.titleTherapeutic strategy in patients with long-lasting essential hypertension with comorbid type 2 diabetes mellitus and obesityen_US
dc.typeArticleen_US
Appears in Collections:Наукові праці. Кафедра гігієни та екології № 1

Files in This Item:
File Description SizeFormat 
Borys O. Shelest et al..pdf344 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.